NCT05429866 2023-03-08Immunological Variables Associated to ICI Toxicity in Cancer PatientsJules Bordet InstitutePhase 2 Unknown441 enrolled
NCT03341845 2018-05-21Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCCThe Netherlands Cancer InstitutePhase 2 Unknown40 enrolled